Lisbeth Bjerring Jensen

654 total citations
13 papers, 524 citations indexed

About

Lisbeth Bjerring Jensen is a scholar working on Immunology, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Lisbeth Bjerring Jensen has authored 13 papers receiving a total of 524 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 5 papers in Molecular Biology and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Lisbeth Bjerring Jensen's work include Complement system in diseases (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Pancreatic function and diabetes (3 papers). Lisbeth Bjerring Jensen is often cited by papers focused on Complement system in diseases (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Pancreatic function and diabetes (3 papers). Lisbeth Bjerring Jensen collaborates with scholars based in Denmark, United Kingdom and Germany. Lisbeth Bjerring Jensen's co-authors include Paul Rolan, Søren Erik Larsen, Vibeke Hatorp, Milan Zdravković, Jeppe Sturis, Henrik Agersø, Grethe Jakobsen, Lennart Andersen, Philip Home and Declan Walsh and has published in prestigious journals such as Diabetes Care, Journal of Pharmaceutical Sciences and Journal of Immunological Methods.

In The Last Decade

Lisbeth Bjerring Jensen

13 papers receiving 489 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lisbeth Bjerring Jensen Denmark 8 347 215 187 66 61 13 524
Alister J. Moody Denmark 9 524 1.5× 240 1.1× 445 2.4× 63 1.0× 266 4.4× 11 826
Dennis M. Hawley United States 11 126 0.4× 317 1.5× 141 0.8× 30 0.5× 43 0.7× 18 421
Hideshi Hirayu Japan 11 259 0.7× 179 0.8× 23 0.1× 88 1.3× 92 1.5× 19 413
S Ohtaki Japan 15 335 1.0× 287 1.3× 35 0.2× 71 1.1× 92 1.5× 35 587
Toshitsugu Kariya Japan 12 92 0.3× 169 0.8× 59 0.3× 25 0.4× 31 0.5× 26 385
Elisabeth Pook Germany 8 140 0.4× 186 0.9× 56 0.3× 13 0.2× 63 1.0× 10 345
Roger Lachance Canada 12 234 0.7× 123 0.6× 38 0.2× 10 0.2× 130 2.1× 26 546
R. Michael Williams United States 8 181 0.5× 90 0.4× 254 1.4× 116 1.8× 293 4.8× 21 484
Tania Kastelic Switzerland 7 43 0.1× 259 1.2× 60 0.3× 56 0.8× 18 0.3× 8 346
Nick Giannoukakis United States 8 68 0.2× 146 0.7× 85 0.5× 55 0.8× 129 2.1× 14 362

Countries citing papers authored by Lisbeth Bjerring Jensen

Since Specialization
Citations

This map shows the geographic impact of Lisbeth Bjerring Jensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisbeth Bjerring Jensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisbeth Bjerring Jensen more than expected).

Fields of papers citing papers by Lisbeth Bjerring Jensen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisbeth Bjerring Jensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisbeth Bjerring Jensen. The network helps show where Lisbeth Bjerring Jensen may publish in the future.

Co-authorship network of co-authors of Lisbeth Bjerring Jensen

This figure shows the co-authorship network connecting the top 25 collaborators of Lisbeth Bjerring Jensen. A scholar is included among the top collaborators of Lisbeth Bjerring Jensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisbeth Bjerring Jensen. Lisbeth Bjerring Jensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
2.
Berger, C, Pierre Cortez, Yann Dean, et al.. (2015). A fit-for-purpose strategy for the risk-based immunogenicity testing of biotherapeutics: a European industry perspective. Journal of Immunological Methods. 417. 1–9. 26 indexed citations
3.
Jensen, Lisbeth Bjerring, et al.. (2013). In Vitro Protein Binding of Liraglutide in Human Plasma Determined by Reiterated Stepwise Equilibrium Dialysis. Journal of Pharmaceutical Sciences. 102(8). 2882–2888. 68 indexed citations
4.
Jørgensen, Poul J., et al.. (2007). Immunogenicity of novel recombinant human activated factor VII analogues on factor VII neonatally-tolerized rats. Thrombosis and Haemostasis. 98(10). 721–725. 4 indexed citations
5.
Lindholm, Anders, Lisbeth Bjerring Jensen, Philip Home, et al.. (2002). Immune Responses to Insulin Aspart and Biphasic Insulin Aspart in People With Type 1 and Type 2 Diabetes. Diabetes Care. 25(5). 876–882. 87 indexed citations
6.
Jakobsen, Grethe, Søren Erik Larsen, Henrik Agersø, et al.. (2002). Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of a Single-Dose of NN2211, a Long-Acting Glucagon-Like Peptide 1 Derivative, in Healthy Male Subjects. Diabetes Care. 25(8). 1398–1404. 237 indexed citations
7.
Andersen, Lennart, P N Jørgensen, Lisbeth Bjerring Jensen, & Declan Walsh. (2000). A New Insulin Immunoassay Specific for the Rapid-Acting Insulin Analog, Insulin Aspart, Suitable for Bioavailability, Bioequivalence, and Pharmacokinetic Studies. Clinical Biochemistry. 33(8). 627–633. 48 indexed citations
8.
Jensen, Lisbeth Bjerring, et al.. (1994). Identification and Removal of Polymer‐ and Aggregate‐Forming Proteins in Human Plasma Albumin Preparations. Vox Sanguinis. 67(2). 125–131. 17 indexed citations
9.
Jensen, Lisbeth Bjerring, et al.. (1994). Identification and Removal of Polymer- and Aggregate- Forming Proteins in Human Plasma Albumin Preparations. Vox Sanguinis. 67(2). 125–131. 3 indexed citations
10.
Slierendrecht, W.J., et al.. (1993). Genetic polymorphism of complement component C3 in rainbow trout (Oncorhynchus mykiss) and resistance to viral haemorrhagic septicaemia. Fish & Shellfish Immunology. 3(3). 199–206. 12 indexed citations
11.
Jensen, Lisbeth Bjerring & Claus Koch. (1992). Use of monoclonal and polyclonal antibodies to analyse the degradation of rainbow trout C3 in inulin-activated serum. Fish & Shellfish Immunology. 2(4). 241–249. 11 indexed citations
12.
Jensen, Lisbeth Bjerring & Claus Koch. (1991). An assay for complement factor B in species at different levels of evolution. Developmental & Comparative Immunology. 15(3). 173–179. 3 indexed citations
13.
Koch, Claus, et al.. (1983). The alternative complement pathway in chickens. Developmental & Comparative Immunology. 7(4). 785–786. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alister J. Moody Breakdown of academic impact, for papers by Dennis M. Hawley Breakdown of academic impact, for papers by Hideshi Hirayu Breakdown of academic impact, for papers by S Ohtaki Breakdown of academic impact, for papers by Toshitsugu Kariya Breakdown of academic impact, for papers by Elisabeth Pook Breakdown of academic impact, for papers by Roger Lachance Breakdown of academic impact, for papers by R. Michael Williams Breakdown of academic impact, for papers by Tania Kastelic Breakdown of academic impact, for papers by Nick Giannoukakis
Rankless by CCL
2026